BACKGROUND: The use of genome-guided drug therapy will certainly influence clinical practice within healthcare. However, in spite of the benefits of pharmacogenomic testing, little is known regarding what clinicians think about this promising technology. OBJECTIVE: The purpose of article was to identify themes within the attitudes of nurses in the field of oncology. MATERIALS & METHODS: The sample included 246 responses to an open-ended question. A thematic analysis of these responses was completed. RESULTS: The analysis uncovered six themes. CONCLUSION: Therefore, future research on the assessment of attitudes of oncology nurses concerning pharmacogenomics should incorporate these themes.
No takes yet. Share an insight, caveat, or question.
Crystal Dodson (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: